Department of Neurosurgery, Saarland University, 66421 Homburg, Saar, Germany.
Acta Neurochir (Wien). 2013 Aug;155(8):1589-94; discussion 1594-5. doi: 10.1007/s00701-012-1562-3. Epub 2012 Nov 28.
LiquoGuard is a new device for intracranial pressure (ICP)-controlled drainage of cerebrospinal fluid (CSF). This present study evaluates the accuracy of ICP measurement via the LiquoGuard device in comparison with Spiegelberg. Thus, we compared data ascertained from simultaneous measurement of ICP using tip-transducer and tip-sensor devices.
A total of 1,764 monitoring hours in 15 patients (range, 52-219 h) were analysed. All patients received an intraventricular Spiegelberg III probe with the drainage catheter connected to the LiquoGuard system. ICP reading of both devices was performed on an hourly basis. Statistical analysis was done by applying Pearson correlation and Wilcoxon-matched pair test (p < 0.05).
Mean ICP values were 11 ± 5 mmHg (Spiegelberg) and 10 ± 7 mmHg (LiquoGuard); the values measured with both devices correlated well (p = 0.001; Pearson correlation =0.349; n = 1,764). In two of the 15 patients with slit ventricles, episodes of significant differences in measured values could be observed. Both patients suffering from slit ventricles failed to produce reliable measurement with the external transducer of the LiquoGuard.
LiquoGuard is a valuable new device for ICP-controlled CSF drainage. However, LiquoGuard tends to provide misleading results in slit ventricles. Thus, before these drawbacks are further analysed, the authors recommend additional ICP measurement with internal tip-sensor devices to avoid dangerous erroneous interpretation of ICP data.
LiquoGuard 是一种用于颅内压(ICP)控制下脑脊液(CSF)引流的新设备。本研究通过与 Spiegelberg 进行比较,评估了 LiquoGuard 设备测量 ICP 的准确性。因此,我们比较了使用尖端换能器和尖端传感器设备同时测量 ICP 所获得的数据。
共分析了 15 例患者(52-219 小时)的 1764 小时监测数据。所有患者均接受脑室 Spiegelberg III 探头,引流导管连接到 LiquoGuard 系统。每小时对两种设备的 ICP 读数进行检测。通过应用 Pearson 相关和 Wilcoxon 配对检验(p<0.05)进行统计分析。
平均 ICP 值分别为 Spiegelberg 11±5mmHg 和 LiquoGuard 10±7mmHg;两种设备测量值相关性良好(p=0.001;Pearson 相关系数=0.349;n=1764)。在 15 例有裂隙脑室的患者中,有两例观察到测量值有显著差异。这两个患有裂隙脑室的患者都无法使用 LiquoGuard 的外部换能器进行可靠的测量。
LiquoGuard 是一种用于 ICP 控制下 CSF 引流的有价值的新设备。然而,LiquoGuard 在裂隙脑室中往往会提供误导性的结果。因此,在进一步分析这些缺点之前,作者建议额外使用内部尖端传感器设备进行 ICP 测量,以避免对 ICP 数据的危险错误解释。